In the TNBS colitis prevention trial, Hif1a and Tgfb1 expression was elevated by MTADV as in the therapeutic trial, but it also caused an increase in Tnfa, Vegfa, and Il10 (Figure 5B). The gene discussed is TGFB1; the disease is colitis.